Atezolizumab
Showing 1 - 25 of 765
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIA Lung Cancer AJCC v8 Trial in Los Angeles (Atezolizumab
Recruiting
- Lung Non-Small Cell Carcinoma
- +10 more
- Atezolizumab and Recombinant Human Hyaluronidase
- Survey Administration
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Jan 31, 2023
Recurrent Glioblastoma Trial (Atezolizumab)
Not yet recruiting
- Recurrent Glioblastoma
- Atezolizumab
- (no location specified)
Oct 3, 2023
Hepatocellular Carcinoma, Hepatocellular Cancer, Hepatocellular Carcinoma Non-resectable Trial in Seoul (Atezolizumab plus
Recruiting
- Hepatocellular Carcinoma
- +4 more
- Atezolizumab plus bevacizumab, combined EBRT to vascular invasion
- Atezolizumab plus bevacizumab
-
Seoul, Korea, Republic ofAsan Medical Center
Aug 7, 2023
Large Cell Neuroendocrine Carcinoma of the Lung Trial in Athens (Atezolizumab, Carboplatin, Etoposide)
Completed
- Large Cell Neuroendocrine Carcinoma of the Lung
- Atezolizumab
- +2 more
-
Athens, Greece
- +1 more
Sep 16, 2023
Colorectal Cancer Trial (all trans Retinoic Acid, Atezolizumab, Bevacizumab)
Not yet recruiting
- Colorectal Cancer
- all trans Retinoic Acid
- +2 more
- (no location specified)
Aug 11, 2023
Hepatocellular Carcinoma, Hepatic Portal Vein Tumor Invasion, Tumor Thrombus Trial (I-125 Seeds Brachytherapy in PVTT,
Not yet recruiting
- Hepatocellular Carcinoma
- +2 more
- I-125 Seeds Brachytherapy in PVTT
- +2 more
- (no location specified)
Aug 14, 2023
Hepatocellular Carcinoma Non-resectable Trial in Taoyuan City (Atezolizumab, Bevacizumab, Proton radiotherapy)
Recruiting
- Hepatocellular Carcinoma Non-resectable
- Atezolizumab
- +2 more
-
Taoyuan City, TaiwanChang Gung Memorial Hospital at Linkou
Nov 17, 2023
Metastatic Microsatellite-stable Colorectal Cancer Trial (LB-100, Atezolizumab)
Not yet recruiting
- Metastatic Microsatellite-stable Colorectal Cancer
- LB-100
- Atezolizumab
- (no location specified)
Sep 1, 2023
Metastatic Hepatocellular Carcinoma Trial in Houston (Atezolizumab, Bevacizumab, ADI-PEG 20)
Not yet recruiting
- Metastatic Hepatocellular Carcinoma
- Atezolizumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 24, 2023
Hepatocellular Carcinoma Trial (Ezurpimtrostat, Atezolizumab, Bevacizumab)
Recruiting
- Hepatocellular Carcinoma
- Ezurpimtrostat
- +2 more
-
Grenoble, FranceUniversity Hospital
Dec 23, 2022
Hepatocellular Carcinoma Trial in Guangzhou (TACE-HACI, plus atezolizumab-bevacizumab)
Recruiting
- Hepatocellular Carcinoma
- TACE-HACI, plus atezolizumab-bevacizumab
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Feb 20, 2023
Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Tucson (Cabozantinib + Atezolizumab)
Recruiting
- Pancreatic Cancer
- Metastatic Pancreatic Cancer
- Cabozantinib + Atezolizumab
-
Tucson, ArizonaUniversity of Arizona Cancer Center
Dec 14, 2022
Carcinoma, Hepatocellular Trial (Atezolizumab, Bevacizumab, Tiragolumab)
Not yet recruiting
- Carcinoma, Hepatocellular
- Atezolizumab
- +3 more
- (no location specified)
Jun 14, 2023
Stage II Melanoma Trial in United States (Atezolizumab, Tiragolumab, Signatera Assay)
Recruiting
- Stage II Melanoma
- Atezolizumab
- +2 more
-
Duarte, California
- +5 more
Nov 10, 2022
Small Cell Lung Cancer Extensive Stage Trial (quaratusugene ozeplasmid, atezolizumab)
Not yet recruiting
- Small Cell Lung Cancer Extensive Stage
- quaratusugene ozeplasmid
- atezolizumab
- (no location specified)
Jan 19, 2023
Atezolizumab Combined With Chemotherapy in Extensive Stage SCLC
Completed
- Small Cell Lung Cancer
- atezolizumab
-
Chalon-sur-SaƓne, France
- +1 more
Jan 5, 2023
Endometrial Cancer, Metastasis Trial (Atezolizumab, ONC201)
Not yet recruiting
- Endometrial Cancer
- Metastasis
- Atezolizumab
- ONC201
- (no location specified)
Sep 12, 2022
Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma Trial (Atezolizumab Injection, Bevacizumab, Transarterial
Not yet recruiting
- Hepatocellular Carcinoma
- BCLC Stage B Hepatocellular Carcinoma
- Atezolizumab Injection
- +2 more
- (no location specified)
Mar 16, 2023
Triple Negative Breast Tumors Trial in Paris (Atezolizumab + RP1)
Not yet recruiting
- Triple Negative Breast Neoplasms
- Atezolizumab + RP1
-
Paris, FranceInstitut Curie
Oct 2, 2023
Squamous Cell Carcinoma of Head and Neck Trial in Essen (Atezolizumab)
Recruiting
- Squamous Cell Carcinoma of Head and Neck
- Atezolizumab
-
Essen, GermanyUniversity Hospital Essen
Nov 2, 2022
Advanced Solid Tumor, CDKN2A, NSCLC Trial (Milademetan, Atezolizumab)
Withdrawn
- Advanced Solid Tumor
- +9 more
- Milademetan
- Atezolizumab
- (no location specified)
Oct 16, 2023